Thomas P Miller

  • 18820 Citations
  • 57 h-Index
1978 …2021
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1979 2016

  • 18820 Citations
  • 57 h-Index
  • 164 Article
  • 2 Chapter
  • 1 Letter
Filter
Article
2016
15 Citations (Scopus)

A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520

Puvvada, S. D., Li, H., Rimsza, L. M., Bernstein, S. H., Fisher, R. I., LeBlanc, M., Schmelz, M., Glinsmann-Gibson, B., Miller, T. P., Maddox, A. M., Friedberg, J. W., Smith, S. M. & Persky, D. O., Jan 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-11 11 p.

Research output: Contribution to journalArticle

Histocompatibility Antigens Class II
B-Cell Lymphoma
Tumor-Infiltrating Lymphocytes
T-Lymphocytes
Tumor Microenvironment
2015
6 Citations (Scopus)

Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313

Persky, D. O., Miller, T. P., Unger, J. M., Perry, C. S., Puvvada, S. D., Dino Stea, B., Press, O. W., Constine, L. S., Barton, K. P., Friedberg, J. W., LeBlanc, M. & Fisher, R. I., Aug 8 2015, In : Blood. 125, 2, p. 236-241 6 p.

Research output: Contribution to journalArticle

Radiotherapy
B-Cell Lymphoma
Consolidation
Cells
Non-Hodgkin's Lymphoma
2014
22 Citations (Scopus)

Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2

Mahadevan, D., Morales, C., Cooke, L. S., Manziello, A., Mount, D. W., Persky, D. O., Fisher, R. I., Miller, T. P. & Qi, W., Jun 3 2014, In : PLoS One. 9, 6, e95184.

Research output: Contribution to journalArticle

vincristine
Vincristine
lethal genes
mice
Tumors
16 Citations (Scopus)

Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma

Gustafson, H. L., Yao, S., Goldman, B. H., Lee, K., Perry, C. S., LeBlanc, M. L., Rimsza, L. M., Cerhan, J. R., Habermann, T. M., Link, B. K., Maurer, M. J., Slager, S. L., Persky, D. O., Miller, T. P., Fisher, R. I., Ambrosone, C. B. & Briehl, M. M., 2014, In : American Journal of Hematology. 89, 6, p. 639-645 7 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Genetic Polymorphisms
Non-Hodgkin's Lymphoma
Single Nucleotide Polymorphism
Oxidative Stress
15 Citations (Scopus)

Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma

Barr, P. M., Miller, T. P., Friedberg, J. W., Peterson, D. R., Baran, A. M., Herr, M., Perry, C. S., Cui, H., Roe, D., Persky, D. O., Casulo, C., Littleton, J., Schwartz, M., Puvvada, S. D., Landowski, T. H., Rimsza, L. M., Dorr, R. T., Fisher, R. I., Bernstein, S. H. & Briehl, M. M., Aug 21 2014, In : Blood. 124, 8, p. 1259-1265 7 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Refractory materials
Non-Hodgkin's Lymphoma
Oxidation-Reduction
Cells
15 Citations (Scopus)

R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433

Friedberg, J. W., Unger, J. M., Burack, W. R., Gopal, A. K., Raju, R. N., Nademanee, A. P., Kaminski, M. S., Li, H., Press, O. W., Miller, T. P. & Fisher, R. I., 2014, In : British Journal of Haematology. 166, 3, p. 382-389 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Vincristine
Prednisone
Doxorubicin
Cyclophosphamide
2013
22 Citations (Scopus)

A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine- tositumomab

Press, O. W., Unger, J. M., Rimsza, L. M., Friedberg, J. W., Leblanc, M., Czuczman, M. S., Kaminski, M., Braziel, R. M., Perry, C. S., Gopal, A. K., Maloney, D. G., Cheson, B. D., Dakhil, S. R., Miller, T. P. & Fisher, R. I., Dec 1 2013, In : Clinical Cancer Research. 19, 23, p. 6624-6632 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Radioimmunotherapy
Disease-Free Survival
Vincristine
Survival
39 Citations (Scopus)

Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment

Qi, W., Perry, C. S., Liu, X., Agarwal, A., Cooke, L. S., Persky, D. O., Chen, D., Miller, T. P. & Mahadevan, D., Apr 2013, In : Leukemia Research. 37, 4, p. 434-439 6 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Non-Hodgkin's Lymphoma
Apoptosis
Cell Line
Therapeutics
74 Citations (Scopus)

A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213

Bernstein, S. H., Epner, E., Unger, J. M., LeBlanc, M., Cebula, E., Burack, R., Rimsza, L. M., Miller, T. P. & Fisher, R. I., Jun 2013, In : Annals of Oncology. 24, 6, p. 1587-1593 7 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Cytarabine
Multicenter Studies
Febrile Neutropenia
Poisons
180 Citations (Scopus)

Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma

Stiff, P. J., Unger, J. M., Cook, J. R., Constine, L. S., Couban, S., Stewart, D. A., Shea, T. C., Porcu, P., Winter, J. N., Kahl, B. S., Miller, T. P., Tubbs, R. R., Marcellus, D., Friedberg, J. W., Barton, K. P., Mills, G. M., LeBlanc, M., Rimsza, L. M., Forman, S. J. & Fisher, R. I., 2013, In : New England Journal of Medicine. 369, 18, p. 1681-1690 10 p.

Research output: Contribution to journalArticle

Autologous Transplantation
Non-Hodgkin's Lymphoma
Transplantation
Control Groups
Disease-Free Survival
31 Citations (Scopus)

Examination of the follicular lymphoma international prognostic index (FLIPI) in the national lymphocare study (NLCS): A prospective US patient cohort treated predominantly in community practices

Nooka, A. K., Nabhan, C., Zhou, X., Taylor, M. D., Byrtek, M., Miller, T. P., Friedberg, J. W., Zelenetz, A. D., Link, B. K., Cerhan, J. R., Dillon, H., Sinha, R., Shenoy, P. J., Levy, D., Dawson, K., Hirata, J. H. & Flowers, C. R., Feb 2013, In : Annals of Oncology. 24, 2, p. 441-448 8 p., mds429.

Research output: Contribution to journalArticle

Follicular Lymphoma
Prospective Studies
Disease-Free Survival
Survival
Watchful Waiting
71 Citations (Scopus)

Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350

Mahadevan, D., Unger, J. M., Perry, C. S., Persky, D. O., Young, F., Leblanc, M., Fisher, R. I. & Miller, T. P., Jan 15 2013, In : Cancer. 119, 2, p. 371-379 9 p.

Research output: Contribution to journalArticle

gemcitabine
Peripheral T-Cell Lymphoma
Methylprednisolone
Etoposide
Platinum
106 Citations (Scopus)

Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus 131iodine-tositumomab for previously untreated follicular non-hodgkin lymphoma: SWOG S0016

Press, O. W., Unger, J. M., Rimsza, L. M., Friedberg, J. W., LeBlanc, M., Czuczman, M. S., Kaminski, M., Braziel, R. M., Perry, C. S., Gopal, A. K., Maloney, D. G., Cheson, B. D., Dakhil, S. R., Miller, T. P. & Fisher, R. I., Jan 20 2013, In : Journal of Clinical Oncology. 31, 3, p. 314-320 7 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Follicular Lymphoma
Non-Hodgkin's Lymphoma
Drug Therapy
Disease-Free Survival
71 Citations (Scopus)

Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: Correlative analysis from a large North American cooperative group trial

Kanakry, J. A., Li, H., Gellert, L. L., Lemas, M. V., Hsieh, W. S., Hong, F., Tan, K. L., Gascoyne, R. D., Gordon, L. I., Fisher, R. I., Bartlett, N. L., Stiff, P., Cheson, B. D., Advani, R., Miller, T. P., Kahl, B. S., Horning, S. J. & Ambinder, R. F., May 2 2013, In : Blood. 121, 18, p. 3547-3553 7 p.

Research output: Contribution to journalArticle

Human Herpesvirus 4
Hodgkin Disease
Viruses
Plasmas
DNA
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Radiotherapy
62 Citations (Scopus)

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: A comprehensive analysis from the North American intergroup trial E2496

Evens, A. M., Hong, F., Gordon, L. I., Fisher, R. I., Bartlett, N. L., Connors, J. M., Gascoyne, R. D., Wagner, H., Gospodarowicz, M., Cheson, B. D., Stiff, P. J., Advani, R., Miller, T. P., Hoppe, R. T., Kahl, B. S. & Horning, S. J., Apr 2013, In : British Journal of Haematology. 161, 1, p. 76-86 11 p.

Research output: Contribution to journalArticle

Dacarbazine
Vinblastine
Bleomycin
Hodgkin Disease
Doxorubicin
2012
45 Citations (Scopus)
Vincristine
B-Cell Lymphoma
Prednisone
Non-Hodgkin's Lymphoma
Doxorubicin
25 Citations (Scopus)

AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas

Qi, W., Liu, X., Cooke, L. S., Persky, D. O., Miller, T. P., Squires, M. & Mahadevan, D., Jun 15 2012, In : International Journal of Cancer. 130, 12, p. 2997-3005 9 p.

Research output: Contribution to journalArticle

Aurora Kinases
docetaxel
B-Cell Lymphoma
Growth
Neoplasms
43 Citations (Scopus)

Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma

Mahadevan, D., Stejskal, A., Cooke, L. S., Manziello, A., Morales, C., Persky, D. O., Fisher, R. I., Miller, T. P. & Qi, W., Apr 15 2012, In : Clinical Cancer Research. 18, 8, p. 2210-2219 10 p.

Research output: Contribution to journalArticle

docetaxel
Vincristine
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Neoplasms
91 Citations (Scopus)

Effectiveness of first-line management strategies for stage I follicular lymphoma: Analysis of the National Lymphocare Study

Friedberg, J. W., Byrtek, M., Link, B. K., Flowers, C., Taylor, M., Hainsworth, J., Cerhan, J. R., Zelenetz, A. D., Hirata, J. & Miller, T. P., Sep 20 2012, In : Journal of Clinical Oncology. 30, 27, p. 3368-3375 8 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Disease-Free Survival
Guidelines
Therapeutics
Whole Body Imaging
43 Citations (Scopus)

Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone

Persky, D. O., Dornan, D., Goldman, B. H., Braziel, R. M., Fisher, R. I., LeBlanc, M., Maloney, D. G., Press, O. W., Miller, T. P. & Rimsza, L. M., Jun 1 2012, In : Haematologica. 97, 6, p. 937-942 6 p.

Research output: Contribution to journalArticle

IgG Receptors
Follicular Lymphoma
Genotype
Monoclonal Antibodies
Drug Therapy
21 Citations (Scopus)

Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: Report from the National LymphoCare Study

Nabhan, C., Byrtek, M., Taylor, M. D., Friedberg, J. W., Cerhan, J. R., Hainsworth, J. D., Miller, T. P., Hirata, J., Link, B. K. & Flowers, C. R., Oct 1 2012, In : Cancer. 118, 19, p. 4842-4850 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Non-Hodgkin's Lymphoma
African Americans
Drug Therapy

Reply to "Fc gamma receptor 3a genotype in follicular lymphoma: The end of the story?" Haematologica. 2012;97(11): e45

Persky, D. O., Dornan, D., Goldman, B. H., Braziel, R. M., Fisher, R. I., LeBlanc, M., Maloney, D. G., Press, O. W., Miller, T. P. & Rimsza, L. M., Nov 1 2012, In : Haematologica. 97, 11

Research output: Contribution to journalArticle

IgG Receptors
Follicular Lymphoma
Genotype
Drug Therapy
2011
48 Citations (Scopus)

Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues

Rimsza, L. M., Wright, G., Schwartz, M., Chan, W. C., Jaffe, E. S., Gascoyne, R. D., Campo, E., Rosenwald, A., Ott, G., Cook, J. R., Tubbs, R. R., Braziel, R. M., Delabie, J., Miller, T. P. & Staudt, L. M., Jun 1 2011, In : Clinical Cancer Research. 17, 11, p. 3727-3732 6 p.

Research output: Contribution to journalArticle

Nuclease Protection Assays
Germinal Center
Lymphoma, Large B-Cell, Diffuse
Paraffin
Formaldehyde
66 Citations (Scopus)

Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma

Qi, W., Cooke, L. S., Liu, X., Rimsza, L. M., Roe, D., Persky, A. M. D. O., Miller, T. P. & Mahadevan, D., Apr 1 2011, In : Biochemical Pharmacology. 81, 7, p. 881-890 10 p.

Research output: Contribution to journalArticle

docetaxel
Mantle-Cell Lymphoma
Tumors
Apoptosis
Neoplasms
2009
81 Citations (Scopus)

A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108

Stopeck, A. T., Unger, J. M., Rimsza, L. M., Bellamy, W. T., Iannone, M. E., Persky, D., Leblanc, M., Fisher, R. & Miller, T. P., 2009, In : Leukemia and Lymphoma. 50, 5, p. 728-735 8 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Vascular Endothelial Growth Factor A
Disease-Free Survival
Mantle-Cell Lymphoma
Vascular Endothelial Growth Factor Receptor
18 Citations (Scopus)

Localized large cell lymphoma: Is there any need for radiation therapy?

Persky, D. O. & Miller, T. P., Sep 2009, In : Current Opinion in Oncology. 21, 5, p. 401-406 6 p.

Research output: Contribution to journalArticle

Lymphoma
Radiotherapy
Drug Therapy
Radiation
Standard of Care
136 Citations (Scopus)

Natural history of cns relapse in patients with aggressive non-hodgkin's lymphoma: A 20-year follow-up analysis of swog 8516-the southwest oncology group

Bernstein, S. H., Unger, J. M., LeBlanc, M., Friedberg, J., Miller, T. P. & Fisher, R. I., Jan 1 2009, In : Journal of Clinical Oncology. 27, 1, p. 114-119 6 p.

Research output: Contribution to journalArticle

Natural History
Non-Hodgkin's Lymphoma
Recurrence
Methotrexate
Cyclophosphamide
1 Citation (Scopus)

Reply to M.C. Chamberlain

Bernstein, S. H., Unger, J. M., LeBlanc, M., Friedberg, J., Miller, T. P. & Fisher, R. I., Jul 20 2009, In : Journal of Clinical Oncology. 27, 21

Research output: Contribution to journalArticle

2008
108 Citations (Scopus)

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP

Rimsza, L. M., LeBlanc, M. L., Unger, J. M., Miller, T. P., Grogan, T. M., Persky, D. O., Mattel, R. R., Sabalos, C. M., Seligmann, B., Braziel, R. M., Campo, E., Rosenwald, A., Connors, J. M., Sehn, L. H., Johnson, N. & Gascoyne, R. D., Oct 15 2008, In : Blood. 112, 8, p. 3425-3433 9 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Gene expression
Nuclease Protection Assays
Paraffin
Genes
165 Citations (Scopus)

Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group Study 0014

Persky, D. O., Unger, J. M., Perry, C. S., Stea, B., LeBlanc, M., McCarty, M. J., Rimsza, L. M., Fisher, R. I. & Miller, T. P., 2008, In : Journal of Clinical Oncology. 26, 14, p. 2258-2263 6 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Radiotherapy
Disease-Free Survival
Lymphoma, Large B-Cell, Diffuse
Non-Hodgkin's Lymphoma
70 Citations (Scopus)

Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder

Swinnen, L. J., Leblanc, M., Grogan, T. M., Gordon, L. I., Stiff, P. J., Miller, A. M., Kasamon, Y., Miller, T. P. & Fisher, R. I., Jul 27 2008, In : Transplantation. 86, 2, p. 215-222 8 p.

Research output: Contribution to journalArticle

interferon alfa-2b
Lymphoproliferative Disorders
Immunosuppressive Agents
Immunosuppression
Prospective Studies
1007 Citations (Scopus)

Stromal gene signatures in large-B-cell lymphomas

Lenz, G., Wright, G., Dave, S. S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., Vose, J., Bast, M., Fu, K., Weisenburger, D. D., Greiner, T. C., Armitage, J. O., Kyle, A., May, L., Gascoyne, R. D., Connors, J. M. & 30 others, Troen, G., Holte, H., Kvaloy, S., Dierickx, D., Verhoef, G., Delabie, J., Smeland, E. B., Jares, P., Martinez, A., Lopez-Guillermo, A., Montserrat, E., Campo, E., Braziel, R. M., Miller, T. P., Rimsza, L. M., Cook, J. R., Pohlman, B., Sweetenham, J., Tubbs, R. R., Fisher, R. I., Hartmann, E., Rosenwald, A., Ott, G., Muller-Hermelink, H. K., Wrench, D., Lister, T. A., Jaffe, E. S., Wilson, W. H., Chan, W. C. & Staudt, L. M., Nov 27 2008, In : New England Journal of Medicine. 359, 22, p. 2313-2323 11 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Lymphoma, Large B-Cell, Diffuse
Survival
Genes
Transcriptome
2007
107 Citations (Scopus)

A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma

Leonard, J. P., Friedberg, J. W., Younes, A., Fisher, D., Gordon, L. I., Moore, J., Czuczman, M., Miller, T. P., Stiff, P., Cheson, B. D., Forero-Torres, A., Chieffo, N., McKinney, B., Finucane, D. & Molina, A., Jul 2007, In : Annals of Oncology. 18, 7, p. 1216-1223 8 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Monoclonal Antibodies
Non-Hodgkin's Lymphoma
Lymphoma
Pharmacokinetics
151 Citations (Scopus)

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

Wiestner, A., Tehrani, M., Chiorazzi, M., Wright, G., Gibellini, F., Nakayama, K., Liu, H., Rosenwald, A., Muller-Hermelink, H. K., Ott, G., Chan, W. C., Greiner, T. C., Weisenburger, D. D., Vose, J., Armitage, J. O., Gascoyne, R. D., Connors, J. M., Campo, E., Montserrat, E., Bosch, F. & 10 others, Smeland, E. B., Kvaloy, S., Holte, H., Delabie, J., Fisher, R. I., Grogan, T. M., Miller, T. P., Wilson, W. H., Jaffe, E. S. & Staudt, L. M., Jun 1 2007, In : Blood. 109, 11, p. 4599-4606 8 p.

Research output: Contribution to journalArticle

Cyclin D1
Point Mutation
Survival Rate
Mantle-Cell Lymphoma
Cyclins
35 Citations (Scopus)

Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma

Roberts, R. A., Sabalos, C. M., LeBlanc, M. L., Martel, R. R., Frutiger, Y. M., Unger, J. M., Botros, I. W., Rounseville, M. P., Seligmann, B. E., Miller, T. P., Grogan, T. M. & Rimsza, L. M., Oct 2007, In : Laboratory Investigation. 87, 10, p. 979-997 19 p.

Research output: Contribution to journalArticle

Nuclease Protection Assays
Lymphoma, Large B-Cell, Diffuse
Paraffin
Formaldehyde
Gene Expression
2006
9 Citations (Scopus)
Non-Hodgkin's Lymphoma
Histology
Therapeutics
Doxorubicin
Vincristine
51 Citations (Scopus)

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions

Rimsza, L. M., Roberts, R. A., Campo, E., Grogan, T. M., Bea, S., Salaverria, I., Zettl, A., Rosenwald, A., Ott, G., Muller-Hermelink, H. K., Delabie, J., Fisher, R. I., Unger, J. M., LeBlanc, M., Staudt, L. M., Jaffe, E. S., Gascoyne, R. D., Chan, W. C., Weisenburger, D. D., Greiner, T. & 2 others, Braziel, R. M. & Miller, T. P., Feb 1 2006, In : Blood. 107, 3, p. 1101-1107 7 p.

Research output: Contribution to journalArticle

Histocompatibility
Lymphoma, Large B-Cell, Diffuse
Genes
Cells
MHC Class II Genes
61 Citations (Scopus)

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival

Roberts, R. A., Wright, G., Rosenwald, A. R., Jaramillo, M. A., Grogan, T. M., Miller, T. P., Frutiger, Y., Chan, W. C., Gascoyne, R. D., Ott, G., Muller-Hermelink, H. K., Staudt, L. M. & Rimsza, L. M., Jul 1 2006, In : Blood. 108, 1, p. 311-318 8 p.

Research output: Contribution to journalArticle

MHC Class II Genes
Histocompatibility
B-Cell Lymphoma
Genes
Cells
632 Citations (Scopus)

Molecular diagnosis of Burkitt's lymphoma

Dave, S. S., Fu, K., Wright, G. W., Lam, L. T., Kluin, P., Boerma, E. J., Greiner, T. C., Weisenburger, D. D., Rosenwald, A., Ott, G., Müller-Hermelink, H. K., Gascoyne, R. D., Delabie, J., Rimsza, L. M., Braziel, R. M., Grogan, T. M., Campo, E., Jaffe, E. S., Dave, B. J., Sanger, W. & 18 others, Bast, M., Vose, J. M., Armitage, J. O., Connors, J. M., Smeland, E. B., Kvaloy, S., Holte, H., Fisher, R. I., Miller, T. P., Montserrat, E., Wilson, W. H., Bahl, M., Zhao, H., Yang, L., Powell, J., Simon, R., Chan, W. C. & Staudt, L. M., Jun 8 2006, In : New England Journal of Medicine. 354, 23, p. 2431-2442 12 p.

Research output: Contribution to journalArticle

Burkitt Lymphoma
Lymphoma, Large B-Cell, Diffuse
Gene Expression Profiling
Gene Expression
Lymphoma
197 Citations (Scopus)

Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: Five-year follow-up of Southwest Oncology Group protocol S9911

Press, O. W., Unger, J. M., Braziel, R. M., Maloney, D. G., Miller, T. P., LeBlanc, M. & Fisher, R. I., Sep 1 2006, In : Journal of Clinical Oncology. 24, 25, p. 4143-4149 7 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Non-Hodgkin's Lymphoma
Drug Therapy
Disease-Free Survival
Survival Rate
2005
70 Citations (Scopus)

A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis

Tome, M. E., Johnson, D. B. F., Rimsza, L. M., Roberts, R. A., Grogan, T. M., Miller, T. P., Oberley, L. W. & Briehl, M. M., Nov 15 2005, In : Blood. 106, 10, p. 3594-3601 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Oxidation-Reduction
Thioredoxins
Chemotherapy
Antioxidants

In Reply [2]

Miller, T. P. & Grogan, T. M., 2005, In : Journal of Clinical Oncology. 23, 35, p. 9030-9031 2 p.

Research output: Contribution to journalArticle

328 Citations (Scopus)

New treatment options have changed the survival of patients with follicular lymphoma

Fisher, R. L., LeBlanc, M., Press, O. W., Maloney, D. G., Unger, J. M. & Miller, T. P., 2005, In : Journal of Clinical Oncology. 23, 33, p. 8447-8452 6 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Prednisone
Vincristine
Survival
Procarbazine
139 Citations (Scopus)

Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma

Czuczman, M. S., Thall, A., Witzig, T. E., Vose, J. M., Younes, A., Emmanouilides, C., Miller, T. P., Moore, J. O., Leonard, J. P., Gordon, L. I., Sweetenham, J., Alkuzweny, B., Finucane, D. M. & Leigh, B. R., 2005, In : Journal of Clinical Oncology. 23, 19, p. 4390-4398 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Anti-Idiotypic Antibodies
Safety
Pharmacokinetics
Therapeutics
69 Citations (Scopus)

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures

Mahadevan, D., Perry, C. S., Della Croce, K., Miller, S., George, B., Riley, C., Warner, S., Grogan, T. M. & Miller, T. P., Dec 2005, In : Molecular Cancer Therapeutics. 4, 12, p. 1867-1879 13 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Lymphoma, Large B-Cell, Diffuse
Neoplasms
Oncogenes
Blood Cells
2004
80 Citations (Scopus)

Diffuse aggressive lymphoma.

Fisher, R. I., Miller, T. P. & O'Connor, O. A., 2004, In : Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. p. 221-236 16 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Mantle-Cell Lymphoma
Drug Therapy
Lymphoma, Large B-Cell, Diffuse
Standard of Care
199 Citations (Scopus)

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: A follow-up study from the Leukemia and Lymphoma Molecular Profiling Project

Rimsza, L. M., Roberts, R. A., Miller, T. P., Unger, J. M., LeBlanc, M., Braziel, R. M., Weisenberger, D. D., Chan, W. C., Muller-Hermelink, H. K., Jaffe, E. S., Gascoyne, R. D., Campo, E., Fuchs, D. A., Perry, C. S., Fisher, R. I., Delabie, J., Rosenwald, A., Staudt, L. M. & Grogan, T. M., Jun 1 2004, In : Blood. 103, 11, p. 4251-4258 8 p.

Research output: Contribution to journalArticle

HLA-DR alpha-Chains
Immunologic Monitoring
MHC Class II Genes
Lymphoma, Large B-Cell, Diffuse
Major Histocompatibility Complex
1002 Citations (Scopus)

Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

Dave, S. S., Wright, G., Tan, B., Rosenwald, A., Gascoyne, R. D., Chan, W. C., Fisher, R. I., Braziel, R. M., Rimsza, L. M., Grogan, T. M., Miller, T. P., LeBlanc, M., Greiner, T. C., Weisenburger, D. D., Lynch, J. C., Vose, J., Armitage, J. O., Smeland, E. B., Kvaloy, S., Holte, H. & 20 others, Delabie, J., Connors, J. M., Lansdorp, P. M., Ouyang, Q., Lister, T. A., Davies, A. J., Norton, A. J., Muller-Hermelink, H. K., Ott, G., Campo, E., Montserrat, E., Wilson, W. H., Jaffe, E. S., Simon, R., Yang, L., Powell, J., Zhao, H., Goldschmidt, N., Chiorazzi, M. & Staudt, L. M., Nov 18 2004, In : New England Journal of Medicine. 351, 21, p. 2159-2169 11 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Survival
Transcriptome
Neoplasms
Biopsy
39 Citations (Scopus)

The limits of limited stage lymphoma

Miller, T. P., 2004, In : Journal of Clinical Oncology. 22, 15, p. 2982-2984 3 p.

Research output: Contribution to journalArticle

Radiotherapy Dosage
Antineoplastic Combined Chemotherapy Protocols
Vincristine
Prednisolone
Non-Hodgkin's Lymphoma